Search Within

Eric J Sherman

Formats
  1. Meeting Abstract (187)
  2. Journal Article (141)
  3. Review (6)
  4. Correspondence (3)
  5. Editorial (3)
  6. Research Letter (2)
  7. Book Section (1)
  8. Guidelines (1)
Groups
  1. Department of Medicine (344)
  2. Head and Neck Service (344)
  3. Solid Tumor Oncology Division (344)
  4. Radiation Oncology, Department of (202)
  5. Surgery (170)
  6. Survivorship Research (158)

More Groups

People
  1. Nancy Lee (198)
  2. Nadeem Riaz (147)
  3. David Pfister (126)
  4. Sean McBride (111)
  5. Richard Wong (108)
  6. Alan Ho (87)

More People

Years
  1. 2025 (5)
  2. 2024 (36)
  3. 2023 (24)
  4. 2022 (29)
  5. 2021 (21)
  6. 2020 (38)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (94)
  2. Journal of Clinical Oncology (84)
  3. Annals of Oncology (19)
  4. Cancer (16)
  5. Head & Neck (16)
  6. Oral Oncology (8)

More Publications

Publishers
  1. Elsevier Inc. (110)
  2. American Society of Clinical Oncology (86)
  3. Oxford University Press (26)
  4. Wiley Blackwell (26)
  5. John Wiley & Sons, Inc. (16)
  6. American Medical Association (11)

More Publishers

Results (344)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Durable efficacy of selpercatinib in patients (pts) with medullary thyroid cancer (MTC): Update of the LIBRETTO-001 trial
    Meeting Abstract

    Kroiss, M.; Sherman, E. J.; Wirth, L. J.; Cabanillas, M. E.; Robinson, B.; Subbiah, V.; Drilon, A. E.; Godbert, Y.; Fasnacht, N.; Soldatenkova, V.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Efficacy of BRAF inhibitor FORE8394 in BRAF V600+ patients
    Meeting Abstract

    Sherman, E. J.; Tsai, F.; Janku, F.; Allen, C.; Yaeger, R.; Ammakkanavar, N.; Butowski, N.; Michelson, G.; Paz, M.; Tussay-Lindenberg, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Methodologic concerns in secondary analysis of KEYNOTE-048 - In reply
    Correspondence

    Yu, Y.; Sherman, E. J.; Lee, N. Y.
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • A pilot study of trametinib in combination with paclitaxel in the treatment of anaplastic thyroid cancer
    Meeting Abstract

    Sherman, E. J.; Michel, L. S.; Kriplani, A.; Dunn, L.; Haque, S.; Bang, D.; Stein, S.; Pfister, D. G.; Ho, A. L.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A pilot study of neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Sherman, E. J.; Ho, A. L.; Ganly, I.; Riaz, N.; Morris, L.; Hung, K. W.; Kriplani, A.; Cracchiolo, J. R.; Cohen, M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Toxicity profiles and survival outcomes among patients with nonmetastatic oropharyngeal carcinoma treated with intensity-modulated proton therapy vs intensity-modulated radiation therapy
    Journal Article

    Youssef, I.; Yoon, J.; Mohamed, N.; Zakeri, K.; Press, R. H.; Chen, L.; Gelblum, D. Y.; McBride, S. M.; Tsai, C. J.; Riaz, N.; more...
    JAMA Network Open (2022)

    Fulltext@MSK | Save
  • LIBRETTO-531: A phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer
    Review

    Wirth, L. J.; Brose, M. S.; Elisei, R.; Capdevila, J.; Hoff, A. O.; Hu, M. I.; Tahara, M.; Robinson, B.; Gao, M.; Xia, M.; more...
    Future Oncology (2022)

    Fulltext@MSK | Save
  • Intra-treatment tumor apparent diffusion coefficient, a quantitative imaging metric, is associated with neck nodal recurrence in de-escalated treatment of HPV-positive oropharyngeal cancer (OPC)
    Meeting Abstract

    Diplas, B.; Han, J.; Paudyal, R.; Oh, J. H.; Sherman, E.; Schoder, H.; Hatzoglou, V.; Yu, Y.; Wong, R. J.; Wray, R.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Development and validation of diagnostic interpretation criteria for evaluation of F-18 Fluoromisonidazole hypoxia PET/CT – Inter-reader reliability and accuracy
    Meeting Abstract

    Wray, R.; Mauguen, A.; Michaud, L.; Leithner, D.; Sherman, E.; Riaz, N.; Humm, J.; Mirtcheva, R.; Boyle, J. O.; Wong, R. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save